Oric Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +11.1% | -3.0% | -7.5% | +7.7% | +6.8% | +7.3% | +10.2% | |
| – | – | – | – | – | – | – | – | – | |
| – | -0.5% | +20.1% | +166.0% | -6.4% | +8.5% | +38.1% | +33.9% | -3.7% | |
| – | -2.0% | +71.2% | +134.4% | +64.0% | +14.0% | +2.1% | +12.6% | +15.1% | |
| – | +3.4% | +23.2% | +169.1% | +6.3% | +16.4% | +19.6% | +29.2% | 0.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +67.3% | -81.9% | -53.9% | +1,775.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -104.4% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.